Induction therapy, Consolidation therapy, Maintenance therapy

2 trials

Sponsors

Japan Adult Leukemia Study Group

Conditions

Philadelphia chromosome negative precursor B acute lymphoblastic leukemiaprecursor T acute lymphoblastic leukemia

Phase 2

Phase II study of multi-agent chemotherapy in patients with adult Philadelphia chromosome negative precursor B acute lymphoblastic leukemia.

Active, not recruitingJPRN-UMIN000010619

Japan Adult Leukemia Study GroupPhiladelphia chromosome negative precursor B acute lymphoblastic leukemia

Start: 2013-07-07Target: 160Updated: 2026-06-29

Phase II study of multi-agent chemotherapy in patients with adult precursor T acute lymphoblastic leukemia.

Active, not recruitingJPRN-UMIN000010642

Japan Adult Leukemia Study Groupprecursor T acute lymphoblastic leukemia

Start: 2013-07-07Target: 28Updated: 2026-06-29

Related Papers

Nelarabine‐combined chemotherapy improves outcome of T‐cell acute lymphoblastic leukemia but shows more severe neurotoxicity: <scp>JALSG</scp> T‐<scp>ALL213</scp>‐O

Cancer Science2024-11-211 citations

JALSG Ph (-) B-ALL213 Study: Pediatric-Type Chemotherapy Improves Prognosis in Adult Ph-Negative Acute Lymphoblastic Leukemia Patients, Including Older Adults

Blood2024-11-05